We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+8.48%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$14.8B
AUM Growth
+$629M
Cap. Flow
-$312M
Cap. Flow %
-2.1%
Top 10 Hldgs %
24.14%
Holding
917
New
50
Increased
256
Reduced
457
Closed
57

Top Buys

Rank Stock Value
1
VERU icon
Veru
VERU
+$53M
2
MELI icon
Mercado Libre
MELI
+$43.2M
3
DAR icon
Darling Ingredients
DAR
+$41.7M
4
JNJ icon
Johnson & Johnson
JNJ
+$33.7M
5
MET icon
MetLife
MET
+$31.1M

Top Sells

Rank Stock Value
1
PEP icon
PepsiCo
PEP
+$46.1M
2
NKE icon
Nike
NKE
+$36.6M
3
ITW icon
Illinois Tool Works
ITW
+$35.8M
4
AAPL icon
Apple
AAPL
+$31.9M
5
GILD icon
Gilead Sciences
GILD
+$29.8M

Sector Composition

Rank Sector Weight
1 Healthcare 33.32%
2 Technology 22.84%
3 Financials 10.04%
4 Consumer Discretionary 7.69%
5 Industrials 7.6%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
APD icon
26
Air Products & Chemicals
APD
$66.3B
$102M 0.69%
330,275
-43,558
-12% -$12.3M
CSCO icon
27
Cisco
CSCO
$450B
$99M 0.67%
2,078,280
-227,324
-10% -$10.3M
ADI icon
28
Analog Devices
ADI
$181B
$95.4M 0.64%
581,462
-20,498
-3% -$3.2M
DIS icon
29
Walt Disney
DIS
$165B
$91.7M 0.62%
1,055,391
-89,406
-8% -$8.55M
NVDA icon
30
NVIDIA
NVDA
$5.01T
$91.4M 0.62%
6,253,700
-964,550
-13% -$14.1M
ADBE icon
31
Adobe
ADBE
$89.5B
$87.7M 0.59%
260,508
-42,168
-14% -$13.5M
ADSK icon
32
Autodesk
ADSK
$44.3B
$87.7M 0.59%
469,109
-3,573
-0.8% -$717K
BIIB icon
33
Biogen
BIIB
$29.9B
$82.5M 0.56%
297,813
+46,654
+19% +$13.2M
HOLX
34
DELISTED
Hologic
HOLX
$79.6M 0.54%
1,063,516
+1,736
+0.2% +$124K
IQV icon
35
IQVIA
IQV
$34.7B
$78.1M 0.53%
381,283
-5,167
-1% -$1.05M
ALNY icon
36
Alnylam Pharmaceuticals
ALNY
$36.3B
$76.2M 0.51%
320,495
-32,553
-9% -$6.94M
WM icon
37
Waste Management
WM
$95.9B
$75.5M 0.51%
481,337
+104,708
+28% +$16.8M
MRNA icon
38
Moderna
MRNA
$21.5B
$75.5M 0.51%
420,127
+174,228
+71% +$28.5M
EMR icon
39
Emerson Electric
EMR
$82.9B
$73.9M 0.5%
768,860
+50,236
+7% +$4.52M
ROK icon
40
Rockwell Automation
ROK
$51.4B
$71.5M 0.48%
277,417
-4,299
-2% -$1.08M
WCN
41
Waste Connections
WCN
$42.8B
$70.7M 0.48%
533,576
-2,748
-0.5% -$374K
AVGO icon
42
Broadcom
AVGO
$1.82T
$70M 0.47%
1,251,300
+41,720
+3% +$2.09M
INCY icon
43
Incyte
INCY
$23.5B
$69.7M 0.47%
867,829
-53,130
-6% -$4.07M
PTC icon
44
PTC
PTC
$13.7B
$68.7M 0.46%
572,552
+11,795
+2% +$1.41M
PFE icon
45
Pfizer
PFE
$140B
$68.4M 0.46%
1,335,538
-100,587
-7% -$4.82M
TRMB icon
46
Trimble
TRMB
$12.3B
$68.2M 0.46%
1,349,068
-33,829
-2% -$1.88M
AMD icon
47
Advanced Micro Devices
AMD
$851B
$66.1M 0.45%
1,020,927
+92,250
+10% +$6.09M
KO icon
48
Coca-Cola
KO
$354B
$65.6M 0.44%
1,030,892
+210,052
+26% +$12.7M
AWK icon
49
American Water Works
AWK
$26.3B
$65M 0.44%
426,218
-3,935
-0.9% -$568K
NKE icon
50
Nike
NKE
$61.9B
$64.6M 0.44%
552,436
-363,267
-40% -$36.6M
1
2
3 4 5

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return

Candriam SCA's Q4 2022 Portfolio in Review

As of Q4 2022, Candriam SCA held 917 positions worth $14.8B, up 4.4% from $14.2B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Candriam SCA's Q4 2022 filing shows 50 new, 256 increased, 457 reduced and 57 closed positions. Its largest new stake was Sarepta Therapeutics: 95,144 shares worth $12.3M. The largest sale was PepsiCo, an estimated $46.1M.

By sector, the portfolio is most concentrated in Healthcare at 33% of assets, up from 32% a quarter earlier, followed by Technology and Financials.

  • Candriam SCA's largest Q4 2022 buy was Sarepta Therapeutics: 95,144 shares worth $12.3M.
  • Candriam SCA added most to Veru in Q4 2022, an estimated $53M increase.
  • Candriam SCA's biggest Q4 2022 reduction was PepsiCo, cutting an estimated $46.1M.
  • Candriam SCA fully exited Global Blood Therapeutics, Inc. in Q4 2022, selling an estimated $24.6M.
  • Candriam SCA's ten largest holdings make up 24% of its $14.8B portfolio in Q4 2022.
  • Candriam SCA opened 50 new positions and closed 57 in Q4 2022.
  • Candriam SCA's portfolio value rose 4.4% quarter-over-quarter to $14.8B.

Based on Candriam SCA's 13F filing for Q4 2022, filed 13 Feb 2023.